DexCom (DXCM) Tops Q3 EPS by 4c
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/15/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
- BOJ eyeing September rate hike, faster pace of tightening, sources say
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- SanDisk upgraded at JPMorgan after investor day; shares climb
- Micron: New Street upgrades to buy, says memory is no longer a cyclical story
Dexcom Reports Third Quarter 2022 Financial Results
October 27, 2022 4:03 PM EDTSAN DIEGO--(BUSINESS WIRE)-- DexCom, Inc. (Nasdaq: DXCM) today reported its financial results as of and for the quarter ended September 30, 2022.
Third Quarter 2022 Financial Highlights:
Revenue grew 18% versus the same quarter of the prior year to $769.6 million on a reported basis and 20% on an organic1 basis. U.S. revenue growth of 17% and international revenue growth of 22% on a reported basis. International revenue growth was 28% on an organic1 basis. GAAP operating income of $147.5 million or 19.2% of revenue, an increase of 100 basis points compared to the third... More